Organization Profile

You just read:

Aeterna Zentaris Completes Patient Recruitment for ZoptEC Phase 3 Study with Zoptarelin Doxorubicin in Advanced Endometrial Cancer

News provided by

Aeterna Zentaris Inc.

Jun 30, 2015, 07:30 ET